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ABSTRACT: Histamine is a biogenic amine that is
indispensable in the efficient functioning of various physio-
logical systems. In previous work, a molecularly imprinted
polymer (MIP) based sensor platform with impedimetric read-
out was presented which could rapidly and at low cost
determine histamine concentrations in buffer solutions within
pH 7−9.1,2 For diagnostic applications, histamine should be
detectable in a wider pH range as it mostly occurs in mildly
acidic environments. To understand this pH-dependent
response of the MIP sensor, we propose a statistical binding
analysis model. Within this model, we predict the theoretical
performance of MIP based on acrylic acid in the required pH range and verify these results experimentally by UV−vis
spectroscopy, microgravimetry, and impedance spectroscopy. Using impedimetric read-out, specific and selective detection of
histamine in the physiologically relevant nanomolar concentration range is possible in neutral and mildly acidic phosphate buffer.
Finally, this sensor platform was used to analyze the histamine concentration of mildly acidic bowel fluid samples of several test
persons. We show that this sensor provides reliable data in the relevant concentration regime, which was validated independently
by enzyme-linked immuno sorbent assay (ELISA) tests.
Histamine is an organic nitrogen compound which was firstdescribed in 1910 by Henry H. Dale and P. P. Laidlaw3
(Figure S-1, Supporting Information). It is produced from the
decarboxylation of the amino acid histidine by the enzyme
histidine decarboxylase. This reaction takes place in the mast
cells and basophils4,5 where histamine is detained in intra-
cellular granules.6 In mast cells isolated from the lung, skin, and
the small intestine, approximately 3−8 pg histamine/cell is
found.7 When the mast cells are exposed to allergens, histamine
is released and the local concentration is increased resulting in
an allergic reaction.8 Another important site of histamine
storage and release are the enterochromaffin-like cells in the
stomach and intestines. There, histamine is involved in
regulating the physiological function of the gut.6 Furthermore,
a high concentration of histamine (1−6 μmol/kg) is present in
the brain where it acts as a neurotransmitter.9
Histamine is naturally present in many fruits, vegetables,
beer, red wine, cheese, and fish.10 The concentration is
relatively low; however, when food is spoiled, the amount can
increase to toxic levels up to 50 mg per 100 g of product,
causing food poisoning.10 Histamine detection is therefore of
great importance for the food industry and food safety. Another
area of substantial interest is biomedical research since
histamine plays a pivotal role in the irritable bowel syndrome
(IBS),11,12 allergies,8 asthma,13 rheumatoid arthritis, and related
diseases.14 For these type of medical applications, the detection
limit should be considerably lower than in the case of food
analysis: in, e.g., blood, the normal physiological concentration
ranges from 200 to 600 nM.15
The most common techniques to detect histamine are high-
performance liquid chromatography (HPLC),16 gas chroma-
tography (GC),17 or enzyme-linked immuno sorbent assay
(ELISA),18 all of which are laborious and expensive. Electro-
chemical techniques are inexpensive; however, the use of these
techniques is limited due to the high oxidation potential (∼1.2
V) of histamine.19 In phosphate buffer of pH 7.1, a detection
limit of 20 μM was established with a diamond electrode using
amperometric detection.20 This concentration is well above the
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physiologically relevant concentration, and further on, no tests
were performed yet in biological samples.
In vitro measurements were performed by Bitziou et al,20,21
who used boron-doped diamond microelectrodes in ampero-
metric mode to detect histamine release from ECL cells and
from gastric mucosa of the guinea pig stomach. The sensor was
proven to be stable, and the signal was not influenced by other
electroactive components such as serotonin, which makes it
suitable for qualitatitve measurements in vitro. However,
quantitative measurements were not performed yet. So far,
first attempts to an in vivo measurement of histamine were
made by Mochizuki et al. and Itoh et al.22,23 They could make
an estimate of the histamine release in the hypothalamus of
anesthetized rats by in vivo microdialysis coupled to HPLC
equipment with a fluorescence detector. Upon administration
of histamine agonists, an increase in the release rate was
observed. However, this technique cannot be directly trans-
ferred to measurement in vivo in humans, and furthermore, no
reference tests with analogous molecules were performed to
demonstrate the selectivity of the sensor platform.
Molecularly imprinted polymers (MIPs) present an interest-
ing alternative to these more traditional techniques of histamine
detection. MIPs are synthetic receptors with imprinted
nanocavities that are able to rebind their target molecule as
specific and selective as an enzyme.24−26 Their use offers several
benefits: First, MIPs can be synthesized at a rather low cost via
established polymer−chemical routes.27,28 Second, MIPs are
robust and can withstand extremes of heat and pH.29,30 Third,
MIPs prepared according to the noncovalent approach have the
potential of being regenerated.31 Until now, there are only a
few reports in the literature about MIPs for histamine
recognition; Tong et al. reported on a MIP based sensor
where zinc(II)-protoporphyrin (ZnPP) was used as a
fluorescent monomer and detection was in the millimolar
range.32 Allender et al. studied various MIPs for pharmaceutical
applications, including MIPs for histamine. A histamine MIP
was prepared with the monomer methacrylic acid, and
detection was subsequently performed with HPLC columns.33
Pietrzyk et al. synthesized a MIP by electropolymerizing
polypyrrole, and a detection limit of 20 μM was reached in
phosphate buffer with an amperometric sensor.34 The first MIP
sensor setup capable of measuring the physiologically relevant
nanomolar concentration range has been developed recently by
Bongaers et al. and Horemans et al.1,2 These measurements
were all performed in buffer solutions, and for future
applications, biological samples are considerably more interest-
ing. The MIP used in these publications was composed of
methacrylic acid (MAA) as functional monomer, ethylene
glycol dimethacrylate (EGDM) as cross-linker, and dimethyl-
sulfoxide (DMSO) as porogen. After bulk polymerization,
particles were ground and fixated onto electrodes using a
polymer adhesive. Subsequently, detection down to the
nanomolar concentration range could be performed by
impedance spectroscopy. In the micromolar range, the quartz
crystal microbalance (QCM)35 proved to be most useful. While
histamine could be measured specifically and selectively at pH
7, at mildly acidic pHs, no binding was observed which is due to
the protonation behavior of the target molecule and the MIP.
This pH dependence was also reported by Trikka et al., which
used a histamine MIP with exactly the same composition, but as
Figure 1. Schematic representations of the protonation states of histamine (above) and of MIP conformations A−D (below) in pH range of 1−14.
Within pH range 1−4, His +2 is the abundant form of histamine while this is MIP D for the MIP conformations. His+ dominates from pH 7 to 9. At
higher pHs, HisN will take over. The results for histamine were adopted from literature.1 For the MIPs, MIP A is the abundant species starting from
pH 5.
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a detection method, a colorimetric assay was used.36 In the pH
Model section, we will now propose a statistical binding model
to explain this pH-dependent sensor response.
pH Model. We are interested in measuring histamine in the
gastro-intestinal tract, where the pH of the fluids varies between
5 and 8.37 The functional monomer MAA, which was used by
Bongaers et al. and Horemans et al., is present in the neutral
(COOH) and deprotonated form (COO−) depending on the
pH of the solution.1,38 At pH 5, which is well below the pKa
(6.5) of MAA, the acid occurs mostly in the neutral form.38 The
target, histamine, occurs in three natural forms; the neutral
form (HisN), the single protonated state (His+), and the
double protonated state (His+2). Up to a pH of 10, the
protonated states are abundant, at higher pH values, the neutral
form will dominate. The relative abundances are illustrated in
Figure 1.1
For the formation of a hydrogen bond, there should be a
hydrogen bond donor and a hydrogen bond acceptor. In the
case of the functional monomer, the neutral methacrylic acid
(COOH) form is a donor. The protonated histamine is also a
donor, and as a result, no hydrogen bonds can be formed which
makes binding to the target unlikely at a pH of 5. For binding
to occur, the monomer should be an acceptor, which is the case
in the deprotonated (COO−) state. To obtain a functional
monomer which is mostly in the deprotonated state at pH 5,
the monomer should be more acidic than MAA and the pKa
value should be lower. Therefore, acrylic acid (AA) was
selected, which has a pKa value of approximately 4.5.
39 With the
following calculations, we will demonstrate that MIPs based on
AA monomers are able to bind histamine at mildly acidic pHs
which is not possible to achieve with MAA as monomer.
Histamine contains two functional sites for hydrogen bond
formation, namely, the amine group and the nitrogen in the
ring next to the double bond. To correct for these two binding
sites, already during the synthesis, two times the amount of
monomer compared to the target was used. The monomer can
be either in the neutral or the deprotonated state and, since per
target molecule two monomers are available, this results into
four possible MIP conformations. They are labeled from A to D
(Figure 1). Situation A represents two functional monomers in
the deprotonated state, while for situation D both monomers
are in the neutral form. In the cases of B and C, there is one
monomer in the neutral and the other in the deprotonated
state. In total, the sum of situations A, B, C, and D is 100%. The
relative abundance of the states is determined by the
Henderson−Hasselbach equation (eq 1):
= + −KpH p log
[COOH]
[COO ]a (1)
As derived from this formula, situations B and C can be
calculated by multiplying the percentage of COOH present by
that of COO−. Directly resulting from this, A and D are equal
to the squared percentage of COO− or COOH, respectively.
For example, at pH 5, the percentage of COO− is 76% and that
of COOH is 24%. The occurrence of MIP A is then equal to
76% squared, which is 58%. For the occurrence of MIP D, this
corresponds to 6%. The other remaining 36% is equally divided
over MIP B and C; therefore, both are present at 18%. The
results for pH 1−14 are shown in Figure 1 and in Table S-1 and
Table S-2 of the Supporting Information.
For histamine to bind to the MIP, at least one, but preferably
two, hydrogen bonds should be formed. The situations in
which two hydrogen bonds, one hydrogen bond, and no
hydrogen bonds are established are shown in Figure 2.
To estimate the probability of hydrogen bond formation, the
probability of the independent events needs to be multiplied
and subsequently summed up. This corresponds to the
following formula (Supporting Information, page S-1, eq 2):
∑
| =
= = | |
∈
n k
P i k P j k
prob ( hydrogen bonds pH )
( ) ( )
i j S( , )
His MIP
n (2)
In this formula, PHis represents the probability of His
+2, His+,
and HisN at pH = k (Table S-1, Supporting Information). PMIP
is the probability of MIP A, B, C, and D at pH = k (Table S-2,
Supporting Information). The probability of hydrogen bond
Figure 2. Overview of situations in which 0, 1, and 2 hydrogen bonds can be formed.
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formation from pH 1 to 14 is shown in Table S-3, Supporting
Information. As an example, we calculate the probability of the
formation of two hydrogen bonds at pH 6. At this pH,
histamine is for 91% in the His +2 state and 9% in the His+ state,
and HisN is not encountered. Therefore, options 2.1, 0.1, 1.1,
and 1.2 (Figure 2) do not have to be taken into account. The
probability of formation of 2 hydrogen bonds is equal to 2.2
and 2.3 summed up. For option 2.2, the probability of His +
(9%) needs to be multiplied by the probability of MIP C (3%),
resulting in a 0.3% probability. For option 2.3, His+2 (91%) is
multiplied by A (94%), which leads to 85.5% probability and, in
total, a probability of the formation of 2 hydrogen bonds of
85.8%. Subsequently, the probability of 1 hydrogen bond
formation is 13.9%, and the probability of 0 hydrogen bonds is
0.3%.
The probability of binding in the pH range of 1−14 was
calculated for the MIP with MAA monomers and for the
developed MIP based on AA monomers (Figure 3). The results
of AA are shown in Table S-3 of the Supporting Information.
Figure 3 shows the probability of hydrogen bond formation
for the MAA and AA MIP in a broad pH range (pH 1−14).
With these MIPs, it is not possible to perform measurements in
strongly basic environments; however, this is outside the scope
of our research. Around neutral pH, both MIPs show a high
theoretical binding probability. As previously mentioned, the
MAA MIP has a very low binding capacity at pH < 7 and is
therefore not suitable for detection of histamine in acidic
environments. In contrast to this, the newly developed MIP
based on AA has a theoretical binding probability of still 94% at
pH 5, which is a significant improvement. We will now also
demonstrate experimentally that histamine can be bound with a
high affinity and selectivity at both neutral and mildly acidic
pHs on the basis of the AA MIP. Furthermore, when combined
with a refined sensor setup, we will show that it is possible to
detect histamine in bowel fluids from the small intestines.
■ EXPERIMENTAL SECTION
Chemical Reagents. Ethylene glycol dimethacrylate
(EGDM), methacrylic acid (MAA), acrylic acid (AA), and
dimethylsulfoxide (DMSO) were purchased from Acros (Geel,
Belgium). Prior to polymerization, the stabilizers in the MAA
and EGDM were removed by filtration over alumina.
Azobusisobutyronitrile (AIBN) was purchased from Fluka
(Buchs, Switzerland). The target molecule histamine was
obtained from Sigma Aldrich. Histidine, nicotine, serotonin,
and betahistine, which are analogues of histamine and were
used to test the selectivity, were obtained from Fluka (Buchs,
Switzerland). All solvents were of analytical grade. They were
purchased from Acros (Geel, Belgium) and used without
further purification. The polyphenylenevinylene (PPV) deriv-
ative, OC1C10-PPV, which served as the immobilization layer
on the impedimetric sensor MIP and nonimprinted polymer
(NIP) electrodes, was synthesized via the sulfinyl precursor
route.40 Besides MIP sensors, this PPV derivative can also be
used for other bioanalytical applications, e.g., as an immobiliza-
tion layer for antibodies.41 All chemical and physical properties
of the conjugated polymer were in agreement with previously
reported data. A homemade 1× phosphate buffered saline
(PBS) solution was used for the impedance measurements. The
human histamine ELISA test was obtained from Gentaur
Molecular Products (Kampenhout, Belgium, product number
CSB E07042h).
MIP Synthesis. As mentioned in the introduction, it is
necessary to use a monomer with a lower pKa to detect
histamine in acidic environments. Therefore, acrylic acid (AA)
with a pKa value of 4.5 was selected.
39 The corresponding MIP
was synthesized according to the following procedure: First, a
mixture of AA (18 mmol), EGDM (72 mmol), and AIBN (0.61
mmol) was dissolved in 7 mL of DMSO together with the
template molecule histamine (9.0 mmol). This solution was
degassed with N2 and polymerized in a UV oven for 12 h. After
polymerization, the bulk polymer was ground and sieved to
obtain microparticles with a size smaller than 25 μm. Finally,
the histamine was removed from the MIP powders by Soxhlet
extraction with methanol (48 h), a mixture of acetic acid/
acetonitrile (1/1) (48 h), and methanol again (12 h). The
extracted powders were dried in vacuum for 12 h at room
temperature. A nonimprinted polymer (NIP) was synthesized
in the same way but without the presence of the target
molecule. The selectivity of the MIP was tested by optical batch
rebinding experiments using chemically similar structures of
histamine, such as betahistine and histidine. Furthermore,
serotonin and nicotine were used because they are similar in
size. For the impedimetric measurements, a MIP imprinted
with betahistine was developed as an alternative test for the
selectivity. The MIP was synthesized with the same procedure
and same molar ratios, but instead of histamine, betahistine was
used as a template molecule. The MIP and NIP powders
mentioned here were used for all further batch-rebinding and
impedimetric measurements.
Preparation of Bowel Fluid and ELISA Test. Bowel fluid
samples from the duodenum were obtained from 3 healthy
volunteers, Persons 1, 2, and 3 and divided over 1 mL
Eppendorf tubes. After collection, the tubes were centrifuged
with 2000g to obtain a clear fluid. The samples were stored at
−80 °C to prevent degradation. Prior to analysis, the samples
were heated up to 37 °C and divided into different aliquots.
One part remained unaltered, while from the other parts the
native histamine was removed by extraction. This was done by
adding 10 mg of MIP powder to 3 mL of the bowel fluid. The
fluid mixture was shaken for 30 min to allow full absorption of
the native histamine, followed by filtration to remove the MIP
Figure 3. Percentage of histamine bound by MIP synthesized from
MAA and AA monomers as calculated by the combinatorial affinity
model. The gray area corresponds to the typical pH range in the
intestinal tract (pH 5−8).37
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particles. The resulting extracted bowel fluid served as a
reference, and furthermore, upon addition of spiked concen-
trations of 2.5, 5, 7.5, 25, and 50 μM, it was possible to
construct a dose−response curve. Subsequently, the impedance
response of the unaltered sample was measured with freshly
prepared MIP and NIP electrodes. With the dose−response
curve, the native histamine concentration could be calculated.
With the unaltered samples, ELISA reference tests were
performed with the human histamine ELISA test from Gentaur
Molecular Products. All samples were measured in triplicate,
and the histamine concentration was calculated by comparing
the optical density of the sample to that of the standard curve
(Figure S-4, Supporting Information). For Person 1, the
histamine concentration was determined to be 870 nM ± 60.
For Person 2, this was found to be 500 nM ± 50 nM, and for
Person 3, it was 460 ± 60 nM, respectively.
Impedance-Spectroscopy Platforms. In previous work,
we have introduced a differential sensor-cell offering several
advantages for biological measurements.42,43 With this setup,
native serotonin plasma concentrations were measured with
relatively small uncertainties and the obtained results were in
full agreement with HPLC reference tests.42 The flow-through
cell is made of PMMA and has an internal volume of 110 μL.
During the measurements, the temperature was fixed to 37 ±
0.02 °C using a homemade proportional-integral-derivative
(PID) (P = 10, I = 5, D = 0.1) controller. The MIP- and NIP-
coated electrodes (reference channel) were installed symmetri-
cally with respect to a gold wire serving as a common counter
electrode. To construct the electrodes, 1 × 1 cm2 aluminum
substrates were spincoated with conductive OC1C10-PPV.
Equal amounts of the MIP and NIP powder were embedded
into the layer by heating up the PPV above its glass transition
temperature. The contact area of each electrode with the liquid
(28 mm2) was defined by O-rings, and the distance to the gold
counter electrode was 1.7 mm. The impedance signals were
measured with a homemade, portable system operating in a
frequency range of 100 Hz to 100 kHz with 10 frequencies per
decade and a scanning speed of 5.7 s per sweep.42 The
amplitude of the AC voltage was fixed to 10 mV under open
circuit conditions.
■ RESULTS AND DISCUSSION
Optical Batch Rebinding Experiments. Batch rebinding
experiments were performed with a Varian Cary 500 UV−vis-
NIR spectrophotometer (Leuven, Belgium). The performance
and selectivity of the synthesized MIPs were analyzed under
various pH conditions. Furthermore, at pH 5, the selectivity
was evaluated with the analogues nicotine, serotonin, histidine,
and betahistine (Figure S-1, Supporting Information).
For the rebinding experiments, 20 mg of MIP or NIP powder
was added to 5 mL of aqueous histamine concentrations in the
range between 0.1 and 1.0 mM. The pH of the aqueous
solutions was adjusted between pH 4 and 9 by the addition of a
hydrochloric acid solution or a sodium hydroxide solution. The
resulting suspensions were shaken for 1 h on a rocking table at
Figure 4. Binding isotherms for the MIP (a) and NIP (b) at pH 4−9. To directly compare the MIP and NIP, the imprint factors (Sb MIP/Sb NIP) at
a free concentration of 0.05 mM were calculated in the pH range of 4−9. (c). The data was fitted with an allometric function of the type y = axb (R2
= 0.95).
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room temperature. After filtration, the free concentration (Cf)
of histamine was determined by UV−vis spectroscopy. Hereby,
the amount of bound histamine per gram of MIP or NIP was
calculated (Sb), and the binding isotherms were constructed.
The binding isotherms for the MIP and NIP of AA for pH 4−9
are demonstrated in Figure 4a,b. Furthermore, the imprint
factor at a given concentration (0.05 mM) was calculated. This
refers to the amount of target molecules bound per gram of the
MIP divided by that of the NIP and is a measure of the
specificity (Sb MIP/Sb NIP). The results in the pH range of 4−
9 are plotted in Figure 4c.
The binding isotherms of the MIP (Figure 4a) and NIP
(Figure 4b) show that at pH 4 the binding is mostly aspecific,
while from pH 5 to 9 histamine can be detected selectively.
This can be explained by the statistical binding analysis model.
At pH 4, there is only a low probability (24%) of hydrogen
bond formation. The theoretical probability of binding in the
pH region of 5−9 is above 90%, which indicates that the MIPs
are able to bind the target selectively as indeed is observed from
experiments. This is confirmed by Figure 4c, which shows the
imprint factor, which is significantly lower (1.5) than at pH 5−
9 (∼4.5). The lower the imprint factor, the less selective is the
binding of histamine.
There are several models to describe such binding isotherms.
The Langmuir model assumes that all the binding sites are
homogeneous, which is clearly not the case with MIPs as there
are aspecific and specific affinity sites. To correct for these
heterogeneous binding sites, the Langmuir−Freundlich or
Freundlich model can be applied.44 These models resulted
both in a fit with a high linearity coefficient (R2 = 0.98).
However, it was decided to show the results of the Freundlich
model, as this uses one parameter less than the Langmuir−
Freundlich model (Figure S-5, Supporting Information). These
isotherms show the distribution of the affinity sites by plotting
the binding energy (Ki) versus that of the number of sites
present (N(Ki)). The sites with a low binding affinity
correspond to the aspecific binding, while the high affinity
binding sites represent the specific binding. The total number
of binding sites for the MIP was 114 ± 0.9 μmol/g, while that
for the NIP is considerably lower with 21 ± 0.4 μmol/g (i.e., an
imprint factor of 5.4). Hereby, it is proven that the MIP
synthesized from acrylic acid, in contrast to the MIP
synthesized from methacrylic acid, can specifically detect
histamine at pH value as low as 5.
To further test the selectivity, the binding of a number of
related molecules was investigated. Histidine was used as an
analogue in previous articles1,2 due to its biological relevance,
being the natural precursor of histamine. In its chemical
structure, however, there is a significant difference: Histidine is
an acid while histamine acts as a base. Therefore, we studied
also the response of betahistine, which is chemically more
similar to histamine. The only difference is that the amine
group of the histamine molecule is substituted by a methyl
group (S-1). The binding isotherms obtained with histamine
and the analogues are presented in Figure S-2 of the Supporting
Information. From this graph, we can observe that the MIPs
bind no more of the chosen analogues than the reference NIP
binds histamine, and therefore, the selectivity of the MIP is
proven. Furthermore, as betahistine binds relatively the most to
the MIP, this was chosen as an analogue for the impedance
measurements.
Impedance Spectroscopy in PBS Buffer. Histamine
occurs mostly in acidic fluids, such as saliva, stomach fluid, and
gastric fluid. It is of clinical relevance to measure in gastric fluid,
as an increase in concentration could be a possible marker of
irritable bowel syndrome (IBS).11,12 The normal histamine
concentration ranges from 500 to 1000 nM, which was
determined by ELISA tests (Preparation of Bowel Fluid and
ELISA Test). The pH lies between pH 5 and 7.5, meaning that
it can vary from slightly acidic to slightly basic.38 Before directly
measuring biological fluid, the specificity and selectivity was
tested in phosphate buffer solution. To cover the entire pH
range of bowel fluids, measurements were performed at pH 5
and 7.
MIP and corresponding NIP particles were immobilized onto
the aluminum electrodes with the procedure described by R.
Thoelen et al.45 By optical microscopy in combination with
image processing (Image J software), the surface coverage was
determined to be 27% ± 2.0 for the MIP and 26% ± 3.0 for the
NIP-loaded electrode. Therefore, the precondition for differ-
ential measurements, having identical particle loadings, is
fulfilled. Next, the flow-through cell was filled with PBS buffer.
After stabilizing the cell with PBS (respectively pH 5 or 7) for
45 min, increasing concentrations (50−1000 nM) of histamine
were added. The corresponding dose−response curves at a
frequency of 316 Hz are shown in Figure 5. This frequency was
selected for two reasons. First, the signal was very stable with
only a standard deviation of 0.1% on the impedance. This
ensures a high signal-to-noise ratio, which is approximately 10
at a concentration of 50 nM in PBS, pH 5. Additionally, we can
make an estimation of the detection limit. The limit of
detection is commonly defined as three times this standard
deviation. Hereby, a detection limit of 15 nM is achieved in
buffer solution. This is well below the physiologically relevant
concentration, which is 500 nM or higher. Second, it was
previously demonstrated that the effect upon binding is mainly
capacitive,38 and therefore, especially, the low frequency regime
should be investigated.
The impedance data for each concentration were normalized
with respect to a starting value of 100% pure PBS, prior to
addition of the target molecule. After the addition step, the
Figure 5. Dose−response curve for MIP and NIP exposed to
increasing concentrations of histamine in PBS. At pH 7, data points are
shown as solid squares (MIP) and open squares (NIP). At pH 5, the
data points are shown are solid circles (MIP) and open circles (NIP).
The error bars are indicated, but if applicable, they can be smaller than
the symbol size. The used fit was allometric (y = axb, with R2 = 0.98).
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sensor was left to stabilize for 10 min. The response value was
then obtained by averaging five data points with an interval of 1
min. Hereby, the measuring time was not significantly
prolonged, and impedance data scattering was reduced to a
minimum.
The impedance results confirmed that the MIP based on AA
monomers can detect histamine at pH 5. In the 0−400 nM
range of histamine in PBS with a pH 5, the dose−response
results can be represented well with a linear fit (R2 = 0.99). For
the physiologically relevant concentration range (500−1000
nM), the data is best represented with an allometric fit (R2 =
0.98) which is due to an increasing occupation of the binding
sites. However, there is still a significant difference between the
impedance response at 500 nM (109.9% ± 0.2) compared to
1000 nM (112.2% ± 0.1), which allows discrimination between
normal and elevated values of histamine.
To test the selectivity, impedance measurements were
performed within the same concentration range for betahistine
(0−1000 nM) as was done for histamine. Additionally,
histamine measurements in the presence of an excess of 1000
times serotonin were performed, which did not significantly
alter the obtained results. To test the cross selectivity, a MIP
was synthesized using betahistine as the template molecule.
The protocol was kept the same as for histamine; for the exact
recipe, we refer to MIP Synthesis. This MIP was also
incorporated into the sensor setup, and subsequently,
impedimetric measurements were performed with increasing
betahistine concentrations (0−750 nM). The obtained results
at a frequency of 316 Hz are shown in Figure S-3 of the
Supporting Information. As the binding is significantly less than
that of the MIP, we can conclude that we can measure
histamine specifically and selectively in the desired pH range5−8
of biological samples. In the rare case that the pH of a patient’s
sample is lower than 5, one can adjust the pH by NaOH
addition or by dilution in order to perform the analysis within
the specified pH range of the sensor. For measurements in
highly acidic samples, one may also consider MIPs synthesized
from a monomer with a lower pKa value.
Histamine in Bowel Fluid and ELISA Tests. As a final
step, the histamine concentration in real biological samples was
investigated. Patient samples from the duodenum were
collected and prepared according to Preparation of Bowel
Fluid and ELISA Test. To perform the measurements, the cell
was first filled with the extracted (nonspiked) bowel fluid of
Person 1. The cell was allowed to stabilize for 90 min until a
0.1% noise ratio was achieved. Subsequently, spiked plasma
samples were introduced one by one via a pumping system.
After waiting each time for 20 min, the impedance results were
determined of the MIP and NIP and averaged over 5 data
points. The impedance values of the MIP−NIP response,
normalized to nonspiked extracted plasma at 316 Hz, are given
in Figure 6.
The impedance change upon exposure to a given histamine
concentration is less pronounced than the measurements
performed in PBS buffer. A possible explanation for this
could be the nonspecific absorption of proteins and bile acids
onto the electrode, which partially block the nanocavities.
However, there is still a clear MIP−NIP difference with
increasing concentrations, as the differential (MIP−NIP) signal
in Figure 6 shows. This can be excellently described with an
allometric fit. With this experimental dose−response curve,
initial (unextracted) bowel fluid concentrations can be
measured and the corresponding histamine concentrations
were determined for Persons 1, 2, and 3 (Table 1). As an
example, in the case of Person 1, an impedance increase of
0.86% ± 0.9 was found which corresponds to an initial
concentration of 800 nM ± 90. For Person 2 and Person 3, the
histamine concentrations were, respectively, 570 nM ± 70 and
500 nM ± 60. To validate the results, reference ELISA tests
were performed. As Table 1 shows, the results obtained by the
sensor and the ELISA tests are nicely within the statistical error
range. The pH was estimated using universal pH paper, which
indicates that the samples are, as was expected, mildly acidic.
■ CONCLUSIONS
Histamine is a biogenic amine which mainly occurs in acidic
fluids, such as saliva and gastric fluid. Commonly, detection is
performed by techniques such as HPLC or ELISA. Sensor
platforms with MIPs as synthetic receptors present a fast and
low-cost alternative to these traditional techniques; however,
previously developed MIPs exhibited pH-dependent binding
behavior which complicated binding in acidic environments.
We have proposed a statistical binding analysis model to
explain this pH-dependent response and, on the basis of
theoretical calculations, developed a MIP capable of detecting
histamine at acidic pHs. These theoretical calculations were
supported by UV−vis batch rebinding experiments, which
demonstrated specific and selective detection of histamine in
the required pH range. With impedance spectroscopy as the
read-out technique, detection could be performed in the
physiologically relevant concentration range. Three intestinal
fluid patient samples were measured, and the determined
Figure 6. Normalized MIP−NIP response of the extracted bowel fluid
of Person A spiked with 2.5, 5, 7.5, 25, and 50 μM histamine. The
graph is fitted with an allometric function (y = axb) with parameters a
= 1.14, b = 0.22, and R2 = 0.97. Unextracted bowel fluid resulted in an
increase of 0.86%, which corresponds to a value of 800 nM ± 90. With
ELISA reference tests, a value of 870 nM ± 60 was found.
Table 1. pH and Histamine Concentrations As Determined
by the Sensor Setup and Reference ELISA Tests for Bowel
Fluid Samples of Persons 1, 2, and 3
persons pH
sensor histamine
concentration (nM)
ELISA histamine
concentration (nM)
P1 5 800 ± 90 870 ± 60
P2 6 570 ± 70 500 ± 50
P3 6 500 ± 60 460 ± 60
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histamine concentrations were in nice agreement with ELISA
reference tests. Summarizing, we have developed a fast and low-
cost method to detect histamine selectively in bowel fluids with
the possibility of transferring the techniques to other analytes in
an array format.
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